Logo do repositório
 
Publicação

Adverse Outcome Pathways (AOPs) development, a tool for predictive nanotoxicology

dc.contributor.authorRolo, Dora
dc.contributor.authorLouro, Henriqueta
dc.date.accessioned2020-07-15T15:39:24Z
dc.date.available2020-07-15T15:39:24Z
dc.date.issued2019-11-25
dc.description.abstractNanomaterials (NMs) have the potential to improve novel and useful wide applications in electronics, chemicals, environmental protection, biological medicine, food and others. Therefore, NMs rapid proliferation presents a dilemma to regulators regarding hazard identification, with increased concerns for public health. Predictive nanotoxicology describes a multidisciplinary approach to NMs evaluation that uses a set of in vitro and in silico methods to forecast the effects on biological systems. This approach offers advantages to traditional hazard assessment methods, such as reducing the reliance on animal studies, associated costs and ethical issues. It may be used with several applications in environmental and human health risk assessment and NMs hazard identification, as well as for regulation. The Adverse Outcome Pathways (AOPs) are the central element of a toxicological knowledge framework, promoted by member countries through OECD, built to support chemical risk assessment based on mechanistic reasoning. AOPs describes a logical sequence of causally linked events at different levels of biological organisation, which follows exposure and leads to an adverse health effect in humans or wildlife. The integrative analysis of the cellular and molecular mechanisms of nanotoxicity towards a definition of key events, may lead to adverse outcomes, driving a sequential line and defining an AOP landscape. Each defined AOP is available for crossing data, linking known and unknown landscapes. Since the biological effects that relate to possible genotoxicity and increased risk of cancer due to NMs exposure are under analysis, the development and assessment of AOPs are important novel strategic tools for predictive nanotoxicology.pt_PT
dc.description.sponsorshipTrabalho realizado com o apoio financeiro da FCT/MCTES através de fundos nacionais (PIDDAC), PTDC/SAU-PUB/29481/2017 e através do Centre for Toxicogenomics and Human Health (ToxOmics), UID/BIM/00009/2013.pt_PT
dc.description.versionN/Apt_PT
dc.identifier.urihttp://hdl.handle.net/10400.18/7051
dc.language.isoengpt_PT
dc.subjectAdverse Outcome Pathwayspt_PT
dc.subjectNanomaterialspt_PT
dc.subjectEnvironmental Genotoxicitypt_PT
dc.subjectGenotoxicidade Ambientalpt_PT
dc.titleAdverse Outcome Pathways (AOPs) development, a tool for predictive nanotoxicologypt_PT
dc.typelecture
dspace.entity.typePublication
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/5876/UID%2FBIM%2F00009%2F2013/PT
oaire.citation.conferencePlaceLisboa, Portugalpt_PT
oaire.citation.titleWorkshop 'Nanotoxicology in the context of the safety assessment of nanomaterials', INSA, 25 novembro 2019pt_PT
oaire.fundingStream5876
person.familyNameRolo
person.familyNameLouro
person.givenNameDora
person.givenNameHenriqueta
person.identifier157627
person.identifier.ciencia-id721D-2BB1-7DB1
person.identifier.orcid0000-0003-2704-8648
person.identifier.orcid0000-0001-9744-7332
person.identifier.scopus-author-id6507971479
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsrestrictedAccesspt_PT
rcaap.typelecturept_PT
relation.isAuthorOfPublication20f7bed7-df28-4557-a4e6-72534cd9a7e7
relation.isAuthorOfPublication2361a951-8b9a-4b90-92d6-f6384003a242
relation.isAuthorOfPublication.latestForDiscovery20f7bed7-df28-4557-a4e6-72534cd9a7e7
relation.isProjectOfPublicatione9cc9728-4f09-4e3a-b30d-53d4429986fb
relation.isProjectOfPublication.latestForDiscoverye9cc9728-4f09-4e3a-b30d-53d4429986fb

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
DR_AOP-Dora Rolo-VF.pdf
Tamanho:
3.53 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: